{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:55:39Z","timestamp":1773262539722,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Government of Jiangsu Province (CN)","award":["WSN-005"],"award-info":[{"award-number":["WSN-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0916-3","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T12:21:11Z","timestamp":1469535671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Linfeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibo","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"issue":"3","key":"916_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000185052","volume":"49","author":"M Zeier","year":"1988","unstructured":"Zeier M, Geberth S, Ritz E, Jaeger T, Waldherr R. Adult dominant polycystic kidney disease\u2014clinical problems. Nephron. 1988;49(3):177\u201383.","journal-title":"Nephron"},{"issue":"10","key":"916_CR2","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1681\/ASN.V7102142","volume":"7","author":"R Torra","year":"1996","unstructured":"Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, et al. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol. 1996;7(10):2142\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"916_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321\u201337. doi: 10.1146\/annurev.med.60.101707.125712 .","journal-title":"Annu Rev Med"},{"issue":"3","key":"916_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2215\/CJN.09500911","volume":"7","author":"AB Chapman","year":"2012","unstructured":"Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2012;7(3):479\u201386. doi: 10.2215\/CJN.09500911 .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"916_CR5","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","volume":"5","author":"GM Fick","year":"1995","unstructured":"Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995;5(12):2048\u201356.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"916_CR6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000282536","volume":"51","author":"T Sulser","year":"1993","unstructured":"Sulser T, Fehr JL, Hailemariam S, Briner J, Hauri D. Papillary renal cell carcinoma associated with autosomal dominant polycystic kidney disease. Urol Int. 1993;51(3):164\u20136.","journal-title":"Urol Int"},{"issue":"9","key":"916_CR7","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V491661","volume":"4","author":"DS Keith","year":"1994","unstructured":"Keith DS, Torres VE, King BF, Zincki H, Farrow GM. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;4(9):1661\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"916_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0090-4295(94)80278-5","volume":"43","author":"Z Gatalica","year":"1994","unstructured":"Gatalica Z, Schwarting R, Petersen RO. Renal cell carcinoma in the presence of adult polycystic kidney disease. Urology. 1994;43(1):102\u20135.","journal-title":"Urology"},{"issue":"9","key":"916_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1726-4901(08)70029-7","volume":"70","author":"YL Chang","year":"2007","unstructured":"Chang YL, Chung HJ, Chen KK. Bilateral renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease. J Chin Med Assoc. 2007;70(9):403\u20135. doi: 10.1016\/S1726-4901(08)70029-7 .","journal-title":"J Chin Med Assoc"},{"issue":"4","key":"916_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5114\/pjp.2013.39340","volume":"64","author":"S Konosu-Fukaya","year":"2013","unstructured":"Konosu-Fukaya S, Nakamura Y, Fujishima F, Kasajima A, Takahashi Y, Joh K, et al. Bilateral papillary renal cell carcinoma and angiomyolipoma in the patients with autosomal dominant polycystic kidney disease: case report of two cases and literature review. Pol J Pathol. 2013;64(4):303\u20137.","journal-title":"Pol J Pathol"},{"issue":"3","key":"916_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","volume":"74","author":"P Hajj","year":"2009","unstructured":"Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B, et al. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology. 2009;74(3):631\u20134. doi: 10.1016\/j.urology.2009.02.078 .","journal-title":"Urology"},{"issue":"1\u20132","key":"916_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000351049","volume":"123","author":"CA Jilg","year":"2013","unstructured":"Jilg CA, Drendel V, Bacher J, Pisarski P, Neeff H, Drognitz O, et al. Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens. Nephron Clin Pract. 2013;123(1\u20132):13\u201321. doi: 10.1159\/000351049 .","journal-title":"Nephron Clin Pract"},{"issue":"Suppl 4","key":"916_CR13","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","volume":"29","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2014;29 Suppl 4:iv15\u201325. doi: 10.1093\/ndt\/gfu017 .","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"916_CR14","first-page":"529","volume":"5","author":"C Coulange","year":"1995","unstructured":"Coulange C, Bretheau D. The annual national epidemiologic survey of tumors of the kidney (April 1993-March 1994: 970 patients). The Committee of Oncology of the French Society of Urology. Prog Urol. 1995;5(4):529\u201339.","journal-title":"Prog Urol"},{"issue":"6","key":"916_CR15","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.urology.2010.12.077","volume":"77","author":"RJ Zagoria","year":"2011","unstructured":"Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77(6):1393\u20137. doi: 10.1016\/j.urology.2010.12.077 .","journal-title":"Urology"},{"issue":"3","key":"916_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00330-006-0415-y","volume":"17","author":"A Boss","year":"2007","unstructured":"Boss A, Clasen S, Kuczyk M, Schick F, Pereira PL. Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol. 2007;17(3):725\u201333. doi: 10.1007\/s00330-006-0415-y .","journal-title":"Eur Radiol"},{"issue":"3","key":"916_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3109\/02656736.2012.666319","volume":"28","author":"HH Sung","year":"2012","unstructured":"Sung HH, Park BK, Kim CK, Choi HY, Lee HM. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses. Int J Hyperthermia. 2012;28(3):227\u201334. doi: 10.3109\/02656736.2012.666319 .","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"916_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00261-011-9828-4","volume":"37","author":"X Zhao","year":"2012","unstructured":"Zhao X, Wang W, Zhang S, Liu J, Zhang F, Ji C, et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging. 2012;37(5):885\u201391. doi: 10.1007\/s00261-011-9828-4 .","journal-title":"Abdom Imaging"},{"issue":"3","key":"916_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/bju.12349","volume":"113","author":"TM Wah","year":"2014","unstructured":"Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int. 2014;113(3):416\u201328. doi: 10.1111\/bju.12349 .","journal-title":"BJU Int"},{"issue":"8","key":"916_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1089\/end.2006.20.569","volume":"20","author":"S Park","year":"2006","unstructured":"Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol. 2006;20(8):569\u201373. doi: 10.1089\/end.2006.20.569 .","journal-title":"J Endourol"},{"issue":"4","key":"916_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00261-009-9551-6","volume":"35","author":"G Salvaggio","year":"2010","unstructured":"Salvaggio G, Campisi A, Lo Greco V, Cannella I, Meloni MF, Caruso G. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging. 2010;35(4):447\u201353. doi: 10.1007\/s00261-009-9551-6 .","journal-title":"Abdom Imaging"},{"issue":"3","key":"916_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00261-010-9665-x","volume":"36","author":"WT Kong","year":"2011","unstructured":"Kong WT, Zhang WW, Guo HQ, Qiu JL, Tang M, Jiang ZM, et al. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Abdom Imaging. 2011;36(3):342\u20137. doi: 10.1007\/s00261-010-9665-x .","journal-title":"Abdom Imaging"},{"issue":"4","key":"916_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.5114\/aoms.2013.37271","volume":"9","author":"R Wu","year":"2013","unstructured":"Wu R, Xu FH, Yao MH, Xie J, Hu B. Contrast-enhanced ultrasonography follow-up after radiofrequency ablation in normal rabbit kidney. Arch Med Sci. 2013;9(4):608\u201313. doi: 10.5114\/aoms.2013.37271 .","journal-title":"Arch Med Sci"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0916-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T20:56:18Z","timestamp":1656881778000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-016-0916-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0916-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"article-number":"193"}}